72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.

72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain. (A) 3D volumetric rendering of coronary arteries, and (B) multiplanar reconstruction, show distal right coronary artery lesion (dashed box). (C) Image from onsite deep learning-based FFR-CT algorithm shows corresponding lesion (arrow). FFR-CT was 0.87. (D) Image from subsequent invasive coronary angiography shows corresponding lesion (arrow). Invasive FFR was 0.85, consistent with absence of hemodynamically significant stenosis. 


May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high-speed onsite deep-learning based fractional flow reserve (FFR)-CT algorithm yielded excellent diagnostic performance for the presence of hemodynamically significant stenosis, with both high interobserver and intraobserver reproducibility. 

“A rapid and accurate onsite approach for determining FFR-CT should address challenges encountered in the clinical adoption of prior FFR-CT implementations,” wrote corresponding author Ronny Ralf Buechel, MD, from University Hospital Zurich in Switzerland. 


In this AJR accepted manuscript, 59 patients (46 men, 13 women; mean age 66.5 years) underwent coronary CTA (including calcium scoring) followed within 90 days by invasive angiography with invasive FFR and/or instantaneous wave-free ratio (iwFR) measurements from December 2014 to October 2021. Coronary artery lesions were considered to show hemodynamically significant stenosis in the presence of invasive FFR ≤0.80 and/or iwFR ≤0.89. A single cardiologist evaluated CTA images using an onsite deep-learning based semiautomated algorithm employing a 3D computational flow dynamics model to determine FFR-CT for coronary artery lesions detected by invasive angiography. Then, time for FFR-CT analysis was recorded. FFR-CT analysis was repeated by the same cardiologist in 26 randomly selected examinations, as well as by a different cardiologist in 45 randomly selected examinations.

Ultimately, Buechel et al.’s onsite deep-learning based FFR-CT algorithm evidenced AUC for hemodynamically significant stenosis—based on invasive angiography—of 0.975, sensitivity of 93.5%, and specificity of 97.7%. Among severely calcified lesions, their same algorithm had AUC of 0.991, sensitivity of 94.7%, and specificity of 95.0%. Moreover, the mean analysis time was 7 minutes and 54 seconds.   

“To our knowledge,” the authors of this AJR accepted manuscript added, “the currently reported mean processing timer represents the fastest reported time for onsite FFR-CT analysis.” 

For more information: www.arrs.org 


Find more ARRS23 conference coverage here 


Related Content

News | Cardiac Imaging

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
News | Artificial Intelligence

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
News | Pediatric Imaging

May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Breast Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a ...

Time May 07, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Subscribe Now